Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda office of oncology drugs | 0.02 | 1 | 6242 | 14 |
fda office of oncology products | 1.25 | 0.8 | 5027 | 74 |
fda division of oncology | 0.41 | 0.4 | 7261 | 26 |
office of oncologic diseases fda | 1.68 | 0.7 | 2610 | 100 |
fda office of clinical pharmacology | 0.31 | 0.4 | 1923 | 39 |
fda oncology drug approvals | 1.32 | 0.5 | 4681 | 52 |
office of new drugs fda | 0.64 | 0.8 | 4025 | 89 |
fda approved oncology drugs | 1.84 | 1 | 7308 | 68 |
fda division of oncology 2 | 1.78 | 0.6 | 5327 | 18 |
fda newly approved oncology drugs | 1.2 | 0.1 | 5885 | 15 |
oncologic drugs advisory committee fda | 1.27 | 0.6 | 8966 | 87 |
fda office of new drugs organization chart | 0.26 | 0.3 | 3782 | 16 |
fda oncology clinical trials | 0.07 | 1 | 2936 | 40 |
fda decisions on new oncological drugs | 1.53 | 0.8 | 5050 | 16 |
new fda oncology approvals | 1.71 | 0.3 | 7267 | 61 |
fda advisory committee oncology | 1.77 | 0.5 | 4746 | 5 |
fda guidance combination oncology | 0.79 | 0.7 | 7018 | 61 |
fda oncology drug approvals 2022 | 1.08 | 0.5 | 2371 | 32 |
fda center for oncology excellence | 0.91 | 0.5 | 5146 | 49 |
fda guidance oncology trial design | 1.89 | 0.4 | 7368 | 82 |